Amsino Medical Group, a prominent global provider of medical consumable devices, has recently secured a significant investment from Novo Tellus, a leading investment firm specializing in long-term investments in the global supply chain. The collaboration between Amsino and Novo Tellus aims to enhance Amsino’s global production, research and development, and commitment to quality to provide enhanced solutions to customers worldwide.
Dr. Richard Y. Lee, Chairman and CEO of Amsino Medical Group, expressed his enthusiasm about the renewed partnership, highlighting Novo Tellus as a growth partner with a shared commitment to innovation and customer value. The collaboration is already in motion to elevate Amsino into a next-generation medical supplier, expanding production facilities in the US and strengthening the supply chain to better serve customers.
Novo Tellus Managing Partner, Loke Wai San, emphasized the strategic opportunity in growing Amsino’s US production to cater to a larger customer base in the domestic market. With a focus on delivering critical medical consumables globally, Amsino is well-positioned to expand its operations and footprint to become a leading supplier of diversified medical products worldwide.
The investment by Novo Tellus was made entirely in equity, without debt, further solidifying the commitment to Amsino’s future growth and development. Amsino Medical Group, known for its extensive portfolio of medical devices including urological, infusion therapy, and patient care products, is dedicated to quality and innovation. As a trusted partner for healthcare providers worldwide, Amsino continues to drive advancements in the medical industry.
Novo Tellus, a private equity firm focused on building lasting technology and industrial companies in Southeast Asia, leverages its expertise in the global technology ecosystem to forge strategic partnerships with management teams. With a track record of building enduring businesses and delivering superior investment returns, Novo Tellus is committed to long-term success.
For more information on Amsino Medical Group and their cutting-edge medical solutions, visit amsino.com. To explore partnership opportunities with Novo Tellus and learn about their investment approach, visit novotellus.com. The collaboration between Amsino and Novo Tellus signifies a transformative step towards advancing the global medical supply chain and providing innovative solutions to healthcare providers worldwide.
Source link